単一細胞分析市場：製品別（消耗品、機器）、手法別（フローサイトメトリー、次世代シーケンス（NGS）、ポリメラーゼ連鎖反応（PCR）、質量分析、その他）、エンドユーザー別（学術・研究機関、バイオ・製薬会社、病院・診断研究所、その他）、アプリケーション別（腫瘍学、免疫学、神経学、幹細胞、非侵襲性出生前診断、体外受精（IVF)、その他）。世界の機会分析および産業予測、2021-2031年

Single Cell Analysis Market By Product (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

世界の単一細胞解析市場は、2021年に26億4150万ドル、2031年には136億1676万ドルに達し、2022年から2031年にかけてCAGR17.8％を記録すると予測されています。単一細胞解析（SCA）は、集団の不均一性を示し、関... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年7月31日	US$5,820 シングルユーザライセンスライセンス・価格情報注文方法はこちら	270	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

世界の単一細胞解析市場は、2021年に26億4150万ドル、2031年には136億1676万ドルに達し、2022年から2031年にかけてCAGR17.8％を記録すると予測されています。
単一細胞解析（SCA）は、集団の不均一性を示し、関心のある少数亜集団を特定し、個々の細胞の特定の形質について知るために不可欠である。マイクロ流体システムは、細胞の直径に近いスケールで動作するため、単一細胞の操作に有用である。高密度に充填されたマイクロウェル内に個々の細胞を迅速かつ決定論的にトラップすることができるマイクロ流体アレイ。このトラッピングアレイは、流速が可変の複数のマイクロ流体サンプル処理ユニットと連結することができ、様々な単一細胞研究に利用できる。なぜなら、単一細胞のトラッピング効率は流速ではなくチャンネル設計によって決定されるからである。SCAは、植物生物学、出生前診断、微生物学、免疫学、神経科学などでも一般的に使用されています。

世界の単一細胞分析市場の成長を促す主な要因としては、単一細胞分析における技術的進歩、製薬・バイオテクノロジー産業における研究開発の増加などが挙げられます。さらに、幹細胞研究の成長、個別化医療への注目の高まり、癌の有病率の急増が市場の成長をさらに後押ししています。しかし、単一細胞分析製品のコストが高いことが、予測期間中の単一細胞分析市場の成長を抑制すると予想されます。逆に、シングルセルシーケンスの高い成長ポテンシャルは、市場プレイヤーに有利な機会を提供すると予想されます。

単一細胞分析市場は、製品、アプリケーション、技術、エンドユーザー、地域に区分されます。製品別に見ると、市場は消耗品と機器に分類されます。アプリケーション別では、腫瘍学、免疫学、神経学、幹細胞、非侵襲的出生前診断、体外受精、その他に分類されます。技術別では、フローサイトメトリー、次世代シーケンシング、ポリメラーゼ連鎖反応、質量分析、その他に分類されます。エンドユーザー別では、学術・研究機関、バイオテクノロジー・製薬企業、病院・診断研究所、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

本レポートで紹介する主要企業は、Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc, 10x Genomics, Illumina, Inc, Bio-Rad Laboratories, Agilent Technologies, Inc, Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies, Berkley Light INC, BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.他、多数。

ステークホルダーにとっての主なメリット
本レポートは、2021年から2031年までの単一細胞解析市場分析の市場セグメント、現在のトレンド、予測、ダイナミクスを定量的に分析し、単一細胞解析市場の優勢な機会を特定します。
●市場調査は、主要な推進要因、阻害要因、機会に関連する情報とともに提供されます。
ポーターのファイブフォース分析により、買い手と供給者の潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、供給者と買い手のネットワークを強化できるようにします。
単一細胞解析市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
単一細胞解析市場の詳細な分析は、市場機会を決定するのに役立ちます。
市場プレイヤーのポジショニングは、ベンチマークを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界別の単一細胞解析の市場動向、キープレイヤー、市場セグメント、アプリケーション分野、市場成長戦略などの分析が含まれています。

主な市場セグメント
製品別
消耗品
消耗品 ●装置
技術別
フローサイトメトリー
次世代シーケンサー（NGS)
ポリメラーゼ連鎖反応（PCR)
質量分析計
その他
エンドユーザー別
学術・研究機関
バイオテクノロジー・製薬会社
病院・診断所
その他
アプリケーション別
オンコロジー
免疫学
神経領域
幹細胞
非侵襲的出生前診断
体外受精（IVF)
その他

地域別
北米
米国
カナダ
メキシコ
欧州
ドイツ
フランス
イギリス
イタリア
スペイン
その他の地域
アジア・パシフィック
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
LAMEA
ブラジル
サウジアラビア
南アフリカ
LAMEAの残りの地域

主な市場関係者
10x Genomics
アジレント・テクノロジー
ベクトン・ディッキンソン＆カンパニー
バイオ・ラッド・ラボラトリーズ
Danaher Corporation (Cytiva Life Sciences)
イルミナ社（Illumina, Inc.
バークレーライト
○ BGI GENOMICS CO.LTD
ディアソリングループ（ルミネクス株式会社）
DOLOMITE BIO
MERCK KGAA
OXFORD NANAOPORE TECHNOLOGIES
QIAGEN N.V
Sartorius AG
STANDARD BIOTOOLS (フルイディグム株式会社)
タカラホールディングス
サーモフィッシャーサイエンティフィック, INC.

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Consumables
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Instruments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Oncology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Immunology
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Neurology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Stem cell
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Non-Invasive Prenatal Diagnosis
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 In-Vitro Fertilization (IVF)
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Others
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES
6.1 Overview
6.1.1 Market size and forecast
6.2 Flow Cytometry
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Next Generation Sequencing (NGS)
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Polymerase Chain Reaction (PCR)
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Mass Spectrometry
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Academic and Research Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Biotechnology and Pharmaceutical Companies
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Hospitals and Diagnostic Laboratories
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.3 North America Market size and forecast, by Application
8.2.4 North America Market size and forecast, by Techniques
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Application
8.2.6.1.3 Market size and forecast, by Techniques
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Application
8.2.6.2.3 Market size and forecast, by Techniques
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Application
8.2.6.3.3 Market size and forecast, by Techniques
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.3 Europe Market size and forecast, by Application
8.3.4 Europe Market size and forecast, by Techniques
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Application
8.3.6.1.3 Market size and forecast, by Techniques
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Application
8.3.6.2.3 Market size and forecast, by Techniques
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Application
8.3.6.3.3 Market size and forecast, by Techniques
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Application
8.3.6.4.3 Market size and forecast, by Techniques
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Application
8.3.6.5.3 Market size and forecast, by Techniques
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Application
8.3.6.6.3 Market size and forecast, by Techniques
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.3 Asia-Pacific Market size and forecast, by Application
8.4.4 Asia-Pacific Market size and forecast, by Techniques
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Application
8.4.6.1.3 Market size and forecast, by Techniques
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Application
8.4.6.2.3 Market size and forecast, by Techniques
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Application
8.4.6.3.3 Market size and forecast, by Techniques
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Application
8.4.6.4.3 Market size and forecast, by Techniques
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Application
8.4.6.5.3 Market size and forecast, by Techniques
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Application
8.4.6.6.3 Market size and forecast, by Techniques
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.3 LAMEA Market size and forecast, by Application
8.5.4 LAMEA Market size and forecast, by Techniques
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Application
8.5.6.1.3 Market size and forecast, by Techniques
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Application
8.5.6.2.3 Market size and forecast, by Techniques
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Application
8.5.6.3.3 Market size and forecast, by Techniques
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Application
8.5.6.4.3 Market size and forecast, by Techniques
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 10x Genomics
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Agilent Technologies, Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Becton, Dickinson and Company
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Bio-Rad Laboratories
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Danaher Corporation(Cytiva Life Sciences)
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Illumina, Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 BERKLEY LIGHTS INC
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 BGI GENOMICS CO. LTD
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 DIASORIN GROUP (LUMINEX CORPORATION)
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 DOLOMITE BIO
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 MERCK KGAA
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 OXFORD NANAOPORE TECHNOLOGIES
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 QIAGEN N.V
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Sartorius AG
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 STANDARD BIOTOOLS (Fluidigm Corporation)
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 TAKARA HOLDINGS INC
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 THERMO FISHER SCIENTIFIC, INC.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments

ページTOPに戻る

Table of Contents

Summary

The global single cell analysis market was valued at $2,641.5 million in 2021, and is projected to reach $13,616.76 million by 2031, registering a CAGR of 17.8% from 2022 to 2031.
Single-cell analysis (SCA) is essential in order to show population heterogeneity, identify minority sub-populations of interest, and learn about the particular traits of individual cells. Microfluidic systems are useful for manipulating single cells since they operate at a scale similar to cell diameter. A microfluidic array capable of quickly and deterministically trapping individual cells in densely packed microwells. This trapping array can be linked with multiple microfluidic sample processing units with variable flow rates for various single-cell studies because the single-cell trapping efficiency is dictated by the channel design rather than the flow rate. SCA is also commonly used in plant biology, prenatal diagnostics, microbiology, immunology, and neuroscience.

The major factors that drive the growth of the global single cell analysis market include technological advancement in single cell analysis and increase in R&D in pharmaceutical and biotechnology industry. In addition, growth in stem cell research, growing focus on personalized medicines and surge in prevalence of cancer further propel the market growth. However, high cost of single cell analysis products is expected to restrain the growth of the single cell analysis market during the forecast period. Conversely, high growth potential of single cell sequencing is anticipated to provide lucrative opportunities to the market players.

The single cell analysis market is segmented into product, application, techniques, end user and region. According to product, the market is categorized into consumables and instruments. By application, it is segregated into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, In-vitro fertilization, others. According to techniques, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include the Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing single cell analysis market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments
By Product
● Consumables
● Instruments
By Techniques
● Flow Cytometry
● Next Generation Sequencing (NGS)
● Polymerase Chain Reaction (PCR)
● Mass Spectrometry
● Others
By End User
● Academic and Research Laboratories
● Biotechnology and Pharmaceutical Companies
● Hospitals and Diagnostic Laboratories
● Others
By Application
● Oncology
● Immunology
● Neurology
● Stem cell
● Non-Invasive Prenatal Diagnosis
● In-Vitro Fertilization (IVF)
● Others

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ U.K.
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ 10x Genomics
○ Agilent Technologies, Inc.
○ Becton, Dickinson and Company
○ Bio-Rad Laboratories
○ Danaher Corporation(Cytiva Life Sciences)
○ Illumina, Inc.
○ BERKLEY LIGHTS INC
○ BGI GENOMICS CO. LTD
○ DIASORIN GROUP (LUMINEX CORPORATION)
○ DOLOMITE BIO
○ MERCK KGAA
○ OXFORD NANAOPORE TECHNOLOGIES
○ QIAGEN N.V
○ Sartorius AG
○ STANDARD BIOTOOLS (Fluidigm Corporation)
○ TAKARA HOLDINGS INC
○ THERMO FISHER SCIENTIFIC, INC.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

皮膚科治療薬市場レポート：2024-2034

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（analysis market）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（薬学的薬物）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（analysis market）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?